Yili Chuanning Biotechnology Co.,Ltd. (SHE: 301301)
China
· Delayed Price · Currency is CNY 12.00
-0.71 (-5.59%)
Oct 11, 2024, 9:30 AM CST
Yili Chuanning Biotechnology Co.,Ltd. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | 1,316 | 940.56 | 411.52 | 111.35 | 229 | 91.39 | Upgrade
|
| Depreciation & Amortization | 541.87 | 550.06 | 547.73 | 524.05 | 491.29 | 455.96 | Upgrade
|
| Other Amortization | 0.93 | 1.04 | 1.32 | 0.66 | 0.53 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -1.34 | - | -0.26 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 26.64 | 50.44 | 31.5 | 16.82 | 1.41 | 4.35 | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.14 | 4.57 | 3.76 | -3.89 | -2.08 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.75 | 45.26 | Upgrade
|
| Other Operating Activities | 74.54 | 84.48 | 138.23 | 167.77 | 176.67 | 190.26 | Upgrade
|
| Change in Accounts Receivable | -870.2 | -274.69 | -424.19 | 78.13 | 163.01 | -104.12 | Upgrade
|
| Change in Inventory | -14.5 | -335.46 | 53.31 | -7.75 | -32.43 | -420.06 | Upgrade
|
| Change in Accounts Payable | -56.84 | 264.92 | -63.77 | -80.07 | -385.53 | -401.16 | Upgrade
|
| Change in Other Net Operating Assets | 17.9 | 17.9 | -3.46 | -0.66 | - | 0.06 | Upgrade
|
| Operating Cash Flow | 1,029 | 1,292 | 691.64 | 803.21 | 649.78 | -146.74 | Upgrade
|
| Operating Cash Flow Growth | -38.34% | 86.86% | -13.89% | 23.61% | - | - | Upgrade
|
| Capital Expenditures | -286.39 | -345.13 | -47.2 | -52.27 | -89.19 | -65.44 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | - | 0.77 | - | - | Upgrade
|
| Investment in Securities | -34.8 | - | -7 | 3.34 | - | - | Upgrade
|
| Other Investing Activities | -7.95 | -8.27 | - | - | 1.66 | - | Upgrade
|
| Investing Cash Flow | -329.12 | -353.37 | -54.2 | -48.16 | -87.53 | -65.44 | Upgrade
|
| Long-Term Debt Issued | - | 851.8 | 1,164 | 932.93 | 4,260 | 938.87 | Upgrade
|
| Long-Term Debt Repaid | - | -2,369 | -1,582 | -1,514 | -4,428 | -686.84 | Upgrade
|
| Net Debt Issued (Repaid) | -423.39 | -1,517 | -417.97 | -581.5 | -167.99 | 252.03 | Upgrade
|
| Issuance of Common Stock | 20.26 | - | 1,050 | - | - | - | Upgrade
|
| Common Dividends Paid | -559.69 | -290.12 | -142.82 | -167.8 | -57.26 | -1.03 | Upgrade
|
| Other Financing Activities | 81.16 | -1.07 | -13.42 | - | 6.65 | -17.28 | Upgrade
|
| Financing Cash Flow | -881.65 | -1,808 | 475.92 | -749.29 | -218.6 | 233.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | -7.72 | 3.33 | 4.1 | -6.51 | -5.13 | 1.8 | Upgrade
|
| Net Cash Flow | -189.91 | -866.11 | 1,117 | -0.76 | 338.53 | 23.33 | Upgrade
|
| Free Cash Flow | 742.18 | 947.26 | 644.44 | 750.94 | 560.59 | -212.19 | Upgrade
|
| Free Cash Flow Growth | -51.94% | 46.99% | -14.18% | 33.96% | - | - | Upgrade
|
| Free Cash Flow Margin | 13.25% | 19.64% | 16.87% | 23.23% | 15.36% | -6.75% | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.42 | 0.33 | 0.40 | 0.28 | - | Upgrade
|
| Cash Income Tax Paid | 648.55 | 529.02 | 283.66 | 134.55 | 174.51 | 70.7 | Upgrade
|
| Levered Free Cash Flow | 753.7 | 877.23 | 538.48 | 712.11 | 1,012 | 61.73 | Upgrade
|
| Unlevered Free Cash Flow | 800.26 | 932.09 | 627.44 | 822.66 | 1,121 | 180.23 | Upgrade
|
| Change in Net Working Capital | 502.62 | 37.47 | 293.63 | -102.23 | -432.16 | 402.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.